Mindfulness app for anxiety in underserved groups fizzles out early

NCT ID NCT06242080

Terminated Symptom relief Sponsor: University of North Carolina, Chapel Hill Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a smartphone app that teaches mindfulness meditation to help Black and Latino adults with anxiety during the COVID-19 pandemic. About 400 participants were assigned to one of two mindfulness programs or a waitlist. The trial was terminated early, so we don't have complete results on whether the app reduced anxiety or improved heart health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mindfulness meditation delivered via a smartphone app
What this could lead to: If it had succeeded, this could have pointed toward a simple, scalable way to reduce anxiety in underserved communities.
What could go wrong: The trial was terminated early, so we don't have clear results. It was also a small, early-stage study focused on a specific group, so findings may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY COVID-19 PANDEMIC

Contacts and locations

Locations

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599-7160, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.